Gilead Sciences (NASDAQ:GILD)

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

After Apple Inc. (NASDAQ: AAPL) announced that it would contribute $350 billion to the U.S. economy, there has been at least some attention to how it gets there. The reality ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Stocks were indicated higher on Tuesday morning, for basically more of the same in gains almost every day of the new year. Now that the bull market is nearly nine ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, December 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Meet Merrill Lynch’s Top Biotech Picks for 2018

While 2017 was a strong year for the markets — especially technology stocks — biotech and health care stocks in general were only able to keep pace. The iShares Nasdaq ...
Read Full Story »

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

After a horrible 2015 and 2016, the biotechnology industry finally came back to life in 2017, shrugging off many of the issues that have clouded the waters, especially during the ...
Read Full Story »

Major Biotechs See Surge in Short Interest

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Extreme Networks, Gilead, MGIC, Micron, Noble Energy, Twitter, US Steel, Wendy’s and More

Stocks keep hitting all-time highs, with over 70 trading days of new market highs so far this year alone. Despite a small "sell the news" sell-off on Tuesday, the Senate's ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

With the U.S. House and the Senate now working together to patch up differences between the two tax reform bills, one thing looks pretty certain: In one shape or another, ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Barrick Gold, Boston Scientific, Chipotle, Gap, Gilead, Goldcorp, Workday and More

Stocks set yet another record on the Dow and S&P, but some top chip and tech names have started finding some cracks after massive gains in 2017. The major indexes ...
Read Full Story »

Why Argus Is Taking a Step Back on Gilead Sciences

Gilead Sciences Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded the stock. Many investors have hoped that the shares will ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Best Buy, Equifax, Gilead, MongoDB, NVIDIA, Rio Tinto, Teva, UPS and More

Stocks were indicated to open lower on Monday, with all major U.S. equity indexes down about 0.3% on average. What investors still need to consider is that the stock indexes ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Despite Poor Earnings Reaction, Analysts Still See Upside for Gilead

A flurry of biotech giants reported earnings this past week, and for the most part they all took a step back, but none more than Celgene, which saw its shares ...
Read Full Story »